Experience with trametinib in a pediatric patient with MAP2K1‐related cervicofacial arteriovenous malformation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Experience with trametinib in a pediatric patient with MAP2K1‐related cervicofacial arteriovenous malformation

Published:2024-08-27 Issue: Volume: Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Swaminathan Neeraja¹^ORCID,Smith Joshua D.²,Parmar Hemant A.³,Gemmete Joseph J.²³⁴,Pipe Steven W.⁵^ORCID,Zopf David A.²

Affiliation:

1. Department of Pediatrics Pediatric Hematology Oncology University of Michigan Ann Arbor Michigan USA

2. Department of Otolaryngology‐Head and Neck Surgery University of Michigan Ann Arbor Michigan USA

3. Department of Radiology University of Michigan Ann Arbor Michigan USA

4. Department of Neurosurgery University of Michigan Ann Arbor Michigan USA

5. Department of Pediatrics and Pathology University of Michigan Ann Arbor Michigan USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.31298

Reference8 articles.

1. Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric BRAF V600–Mutant Low-Grade Glioma

2. Extracranial Arteriovenous Malformations: Natural Progression and Recurrence after Treatment

3. Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy

4. Somatic MAP2K1 Mutations Are Associated with Extracranial Arteriovenous Malformation

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP